Login / Signup

Carcinoembryonic antigen kinetics predict response to first-line treatment in metastatic colorectal cancer: Analysis from PRODIGE 9 trial.

Delphine SalfatiMargaux HuotThomas AparicioCome LepageJulien TaiebOlivier BouchéValérie BoigeJean-Marc PhelipLaetitia DahanJaafar BennounaKarine Le MalicotOlayide BoussariJean-Marc Gornet
Published in: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver (2023)
Variations in CEA kinetics correlate with prognosis in patients receiving first-line chemotherapy for mCRC. We propose here a user-friendly application to classify CEA trajectory.
Keyphrases
  • metastatic colorectal cancer
  • clinical trial
  • study protocol
  • phase iii
  • phase ii
  • locally advanced
  • randomized controlled trial
  • squamous cell carcinoma